Cognition Therapeutics

Cognition Therapeutics is a clinical stage biotechnology company developing small molecule oral therapies for neurodegenerative diseases, with a primary focus on Alzheimer’s disease and dementia with Lewy bodies. Its website centers on the advancement of its investigational drug candidate zervimesine, clinical trials, disease specific pipeline work... , and underlying neuroscience aimed at protecting synaptic function and slowing disease progression. Although the company is still in the research and clinical development stage and does not present marketed therapies, the core business shown is the discovery and development of pharmaceutical therapeutics for central nervous system disorders rather than contract research or diagnostic laboratory services.Read More